Table 2.
Infection characteristics.
| Variable presented as #(%) or median (IQR) | Ceftriaxone (n = 20) | SOCT alone (n = 23) | P value |
|---|---|---|---|
| Infection acquisition | |||
| Community | 11 (55) | 10 (43.5) | 0.451 |
| Healthcare | 5 (25) | 9 (39.1) | 0.324 |
| Nosocomial | 4 (20) | 4 (17.4) | 1.000 |
| Infection source | |||
| Bone/joint | 4 (20) | 7 (30.4) | 0.434 |
| Central line | 3 (15) | 6 (26.1) | 0.467 |
| Central nervous system | 1 (5) | 0 (0) | 0.465 |
| Infective endocarditis (native valve) | 0 (0) | 1 (4.3) | 1.000 |
| Respiratory tract | 0 (0) | 3 (13) | 0.236 |
| Skin/soft tissue/wound | 3 (15) | 4 (17.4) | 1.000 |
| Surgical site | 2 (10) | 0 (0) | 0.210 |
| Unknown | 3 (15) | 1 (4.3) | 0.323 |
| Source control | |||
| Controlled | 15 (75) | 18 (78.3) | 1.000 |
| Not controlled | 3 (15) | 3 (13) | 1.000 |
| Unknown | 2 (10) | 2 (8.7) | 1.000 |
| Time to bloodstream clearance, days | 5 [3–6] | 4 [4–6] | 0.892 |
| Infectious diseases consult | 19 (95) | 18 (78.3) | 0.192 |